Neogen Corporation (NEOG) Securities Fraud Lawsuit Explained

A class action lawsuit has been filed against Neogen Corporation (NEOG) alleging securities fraud between January 2023 and June 2025. Defendants allegedly made false and misleading statements about the integration with 3M Company, downplaying "inefficiencies" that arose. Investors who lost money are eligible for a potential settlement.

Neogen Corporation (NEOG), a biotechnology company, is facing a class action lawsuit alleging securities fraud between January 2023 and June 2025. The lawsuit, filed on behalf of investors who lost money, claims that Neogen made false and misleading statements about the integration with the 3M Company, downplaying inefficiencies that arose during the process.

According to the lawsuit, Neogen issued materially false and misleading statements, which led investors to believe that the integration with 3M was progressing better than it actually was. The complaint also alleges that even when Neogen was forced to reveal inefficiencies, the company downplayed them and assured investors that they were committed to resolving them quickly.

The lawsuit seeks to recover losses for investors who were adversely affected during the relevant time frame. Investors who suffered losses are encouraged to contact law firms representing the class action. The deadline to request appointment as lead plaintiff is September 16, 2025.

Neogen's stock price has been volatile, with significant drops reported on January 10, 2025, April 9, 2025, and June 4, 2025, following disclosures of financial issues related to the integration with 3M. The company has not yet responded to the lawsuit.

Investors who wish to learn more about the lawsuit or their rights should contact the law firms involved. There is no cost to participate, and investors may retain counsel of their choice or take no action and remain an absent member of the class action.